Brook Byers

Mr Brook H Byers
Formerly, Brook served as a director of Idec Pharmaceuticals (chairman), Athena Neurosciences (chairman), Signal Pharmaceuticals, Arris Pharmaceuticals, Onyx Pharmaceuticals, Hybritech (chairman), Genprobe and others. These companies have pioneered the medical use of molecular biology, monoclonal antibodies, personalized medicine, molecular diagnostics, genomics and sequencing. He also previously served as the president and a director of the Western Association of Venture Capitalists. Brook is a current board member of the University of California, San Francisco, Medical Foundation, the New Schools Foundation, Stanford University's Bio-X Advisory Council and the Stanford Eye Council. Formerly, he served as co-chair of the five-year, US$1.4 billion UCSF capital campaign. In 2007, UCSF awarded Brook the UCSF Medal, its honorary degree equivalent. In 2008, Brook was elected a fellow of the American Academy of Arts and Sciences. In 2009, he received the Lifetime Achievement Award from the National Venture Capital Association. Brook is a former director of the Entrepreneurs Foundation, the California Healthcare Institute, the Asian Art Museum in San Francisco, the Stanford Graduate School of Business Advisory Council, the That Many May See (UCSF) Vision Research Foundation (chairman) and the Georgia Tech Advisory Board. He was also a founder of TechNet. Raised in Atlanta, Georgia, Brook graduated with a bachelor's degree in electrical engineering from Georgia Tech and received an M.B.A. from Stanford University.
In 2010, he received an honorary Ph.D. from Georgia Institute of Technology.

Career

Venture capital firm.
Founder
Position:
Partner (Menlo Park) (current)

Add education